FilingReader Intelligence

Henlius sees board changes as directors retire

August 12, 2025 at 11:14 AM UTC•By FilingReader AI

Shanghai Henlius Biotech will propose Dr. Jun Zhu's re-appointment as executive director at its extraordinary general meeting on August 29, 2025.

Key non-executive directors Mr. Yifang Wu, Mr. Deyong Wen, and Dr. Guoping Zhao will retire from the fourth board session.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

Primary Source Document

(1) PROPOSED APPOINTMENT OF DIRECTORS OF THE FOURTH SESSION OF THE BOARD (2) PROPOSED APPOINTMENT OF SHAREHOLDER REPRESENTATIVE SUPERVISORS OF THE FOURTH SESSION OF THE BOARD OF SUPERVISORS (3) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION (4) PROPOSED AMENDMENTS TO RELEVANT RULES OF PROCEDURES AND CERTAIN REGULATIONS AND SYSTEMS OF THE COMPANY AND NOTICE OF EXTRAORDINARY GENERAL MEETINGAugust 12, 2025 at 10:56 AM UTC

Shanghai Henlius Biotech, Inc

HKEX:2696•Hong Kong Exchange

RSS feed for Shanghai Henlius Biotech, Inc

News Alerts

Get instant email alerts when Shanghai Henlius Biotech, Inc publishes news

Free account required • Unsubscribe anytime

Browse RSS Feeds

Filing Activity Timeline

View Complete Filing History →